Business
Press Release Jul 12 2023
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated July 12, 2023, titled "APL Healthcare receives USFDA Approval for Sevelamer Hydrochloride Tablets 400 mg and 800 mg.".
About this update from Aurobindo Pharma Ltd
[{"type":"text","content":" Aurobindo Pharma Limited has informed the Exchange regarding a press release dated July 12, 2023, titled \"APL Healthcare receives USFDA Approval for Sevelamer Hydrochloride Tablets 400 mg and 800 mg.\". View Attachment","length":369,"tagName":"div"}]